Abstract
To determine the combined efficacy of piperlongumine and gemcitabine for treatment of KRAS mutant lung cancer. The cell growth inhibition of piperlongumine, gemcitabine, and piperlongumine plus gemcitabine was measured by Cell Counting Kit‑8 assay and the combination index was calculated. In addition, the combined effects of piperlongumine and gemcitabine on cell apoptosis, reactive oxygen species (ROS) contents, and microtubule-associated protein 1 light chain 3B (LC3B) expression were examined. Piperlongumine increased ROS contents and LC3B-II expression. Following the combined treatment with piperlongumine and 10 mM N-acetyl-L-cysteine (NAC), intracellular ROS and cell viability returned to normal levels, and the expression of LC3B-II decreased to the predose level. Gemcitabine also induced cell apoptosis, increased ROS contents, and LC3B-II expression. The combination of piperlongumine with gemcitabine exhibited a synergetic anticancer activity with the combination index <1. The combined application of gemcitabine and piperlongumine yielded synergistic effects on cell apoptosis, but failed to synergistically increase ROS levels and LC3B-II expression. Combination therapy with piperlongumine and gemcitabine is a promising tr...Continue Reading
References
Jan 6, 2005·The Oncologist·Bea PauwelsJan B Vermorken
Jul 15, 2011·Nature·Lakshmi RajSam W Lee
Sep 18, 2012·Molecular Pharmaceutics·Elodie MoysanJean-Pierre Benoit
Apr 23, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·H RandhawaK M Reindl
Jun 7, 2013·The Journal of Biological Chemistry·Sumit AroraAjay P Singh
Aug 21, 2013·Autophagy·Jessie Yanxiang Guo, Eileen White
Oct 5, 2013·Cell Death & Disease·Y WangZ-X Xu
Jan 16, 2014·The AAPS Journal·Ling ZhouPing Li
Aug 2, 2014·European Journal of Pharmacology·Lucas de Sousa Cavalcante, Gisele Monteiro
Sep 2, 2014·International Journal of Oncology·Hanns MöhlerKarl Frei
Dec 21, 2014·Molecular Cancer Therapeutics·Huai-Qiang JuPaul J Chiao
Jan 27, 2015·Acta Pharmacologica Sinica·Xin-xin XiongXiao-qian Chen
Jun 6, 2016·Current Pharmaceutical Design·Sahdeo Prasad, Amit K Tyagi
Sep 8, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marco B E SchaafKasper M A Rouschop
Dec 4, 2016·Aging·Yingying WangGuangrong Zheng
Sep 16, 2017·Apoptosis : an International Journal on Programmed Cell Death·Sunisa ThongsomChutima Talabnin
Mar 16, 2018·Nutrition and Cancer·Xuejiao SongJingyuan Xiong
Mar 20, 2018·Journal of Experimental & Clinical Cancer Research : CR·Meng-Shih WengMing-Hsien Chien
Mar 27, 2018·Biotechnology and Applied Biochemistry·Jinhui ZhuJiale Zhou
Jun 6, 2018·Frontiers in Physiology·Zewen LiuLi Zuo
Jul 15, 2018·European Journal of Medicinal Chemistry·Kamil PiskaElżbieta Pękala
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal
Oct 18, 2018·Cancer Research·Nurbubu T MoldogazievaAlexander A Terentiev
Nov 7, 2018·Anticancer Research·Fernanda DA Silva MachadoMariana Roesch-Ely
Aug 14, 2019·Nature Reviews. Cancer·Ferdinandos Skoulidis, John V Heymach
Nov 2, 2019·Nature·Jude CanonJ Russell Lipford
Feb 6, 2020·Translational Lung Cancer Research·Sutima LuangdilokVirote Sriuranpong
Feb 6, 2020·Cancer Treatment Reviews·Misako NagasakaAsfar S Azmi